Trial Details
COMPLETEDBasic Information
| Clinical ID | c1463 |
|---|---|
| Identifier | NCT04353791 |
| Trial Title | Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis Chronic Moderate|Ulcerative Colitis Chronic Severe |
| Interventions | DRUG: OST-122|DRUG: Placebo |
Participant Information
| Sponsor | Oncostellae S.L |
|---|---|
| City | Santiago de Compostela |
| Country/Region | Spain |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2020-09-16 |
|---|---|
| Primary Completion Date | 2022-12-27 |
| Completion Date | 2022-12-27 |